Received Oct 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
Reports she had previously taken all 5 Pfizer covid shots and has covid and is prescribed Paxlovid; Reports she had previously taken all 5 Pfizer covid shots and has covid and is prescribed Paxlovid; This is a spontaneous report received from a Consumer or other non HCP. A 79-year-old female patient received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for Covid-19 Immunization; Bnt162b2 (DOSE 2, SINGLE), for Covid-19 Immunization; Bnt162b2 (DOSE 3 (BOOSTER), SINGLE), for Covid-19 Immunization; Bnt162b2 (DOSE 4 (BOOSTER), SINGLE), for Covid-19 Immunization. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Reports she had previously taken all 5 Pfizer covid shots and has covid and is prescribed Paxlovid". Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical information: Reported she had previously taken all 5 Pfizer covid shots and had covid and was prescribed Paxlovid. The information on the batch/lot number for BNT162b2 omicron (lp.8.1) will be requested and submitted if and when received.